Pherin Pharmaceuticals, Inc.
Records under this name other than the patents Pherin Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 10 of 10 · Back to Pherin Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,722,652 | Acute treatment of social phobia Term ended Ended no later than Sep 9, 2025 · From the USPTO record | Term ended | Ended no later than Sep 9, 2025 | From the USPTO record |
| US 6,331,534 | Steroids as neurochemical stimulators of the VNO to alleviate pain Term ended Term ended Aug 28, 2017 · From the USPTO record | Term ended | Term ended Aug 28, 2017 | From the USPTO record |
| US 6,117,860 | Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia Term ended Term ended Jul 23, 2017 · From the USPTO record | Term ended | Term ended Jul 23, 2017 | From the USPTO record |
| US 6,555,531 | Weight promoting composition, method, and product Lapsed on the fee record Ended Apr 29, 2015 · From the USPTO record | Lapsed on the fee record | Ended Apr 29, 2015 | From the USPTO record |
| US 6,544,971 | Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices Lapsed on the fee record Ended Apr 8, 2015 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2015 | From the USPTO record |
| US 7,087,430 | Human VNO cDNA libraries Lapsed on the fee record Ended Aug 8, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 8, 2014 | From the USPTO record |
| US 6,242,619 | 19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function Lapsed on the fee record Ended Jun 5, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2013 | From the USPTO record |
| US 6,352,980 | Estrenes for inducting hypothalamic effects Term ended Ended no later than Jan 7, 2011 · From the USPTO record | Term ended | Ended no later than Jan 7, 2011 | From the USPTO record |
| US 5,792,757 | 19-Nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function Term ended Term ended no later than Aug 11, 2018 · Low confidence | Term ended | Term ended no later than Aug 11, 2018 | Low confidence |
| US 5,965,552 | Androstane steroids as neurochemical initators of change in human hypothalamic compositions and methods Term ended Term ended no later than Oct 12, 2019 · Low confidence | Term ended | Term ended no later than Oct 12, 2019 | Low confidence |